Nan Wang

No. 83, Wenhua Road, Shenhe District
Shenyang, 110016, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 17 publications

Prophylactic use of antiepileptics in spontaneous intracerebral hemorrhage: a systematic review and meta-analysis focusing on early seizures and clinical determinants.

Prophylactic use of antiepileptics in spontaneous intracerebral hemorrhage: a systematic review and meta-analysis focusing on early seizures and clinical determinants.

Journal: Neurosurgical review

Published: February 22, 2026

A multimodal deep learning model for predicting impending rupture in symptomatic abdominal aortic aneurysms using CTA and clinical data.

A multimodal deep learning model for predicting impending rupture in symptomatic abdominal aortic aneurysms using CTA and clinical data.

Journal: Frontiers in cardiovascular medicine

Published: December 19, 2025

Predicting the growth of asymptomatic small abdominal aortic aneurysms (AAA) based on deep learning.

Predicting the growth of asymptomatic small abdominal aortic aneurysms (AAA) based on deep learning.

Journal: Frontiers in physiology

Published: September 13, 2025

A novel GSK3β inhibitor ameliorates tau aggregation and neuroinflammation in Alzheimer's disease.

A novel GSK3β inhibitor ameliorates tau aggregation and neuroinflammation in Alzheimer's disease.

Journal: Neurochemistry international

Published: August 18, 2025

Correction: Multi-Target Inhibitor of ZJQ- 3 F Against AChE/BACE1/GSK3β Targets Improves the Cognitive Impairment of APP/PS1/Tau Triple-Transgenic Mouse Models of Alzheimer's Disease.

Correction: Multi-Target Inhibitor of ZJQ- 3 F Against AChE/BACE1/GSK3β Targets Improves the Cognitive Impairment of APP/PS1/Tau Triple-Transgenic Mouse Models of Alzheimer's Disease.

Journal: Molecular neurobiology

Published: August 07, 2025

Discovery of a novel Xanthone derivative P24 for anti-AD via targeting sTGFBR3.

Discovery of a novel Xanthone derivative P24 for anti-AD via targeting sTGFBR3.

Journal: European journal of medicinal chemistry

Published: June 26, 2024

Soluble TGF-β decoy receptor TGFBR3 exacerbates Alzheimer's disease pathology by modifying microglial function.

Soluble TGF-β decoy receptor TGFBR3 exacerbates Alzheimer's disease pathology by modifying microglial function.

Journal: Glia

Published: January 09, 2024

Multi-Target Inhibitor of ZJQ- 3 F Against AChE/BACE1/GSK3β Targets Improves the Cognitive Impairment of APP/PS1/Tau Triple-Transgenic Mouse Models of Alzheimer's Disease.

Multi-Target Inhibitor of ZJQ- 3 F Against AChE/BACE1/GSK3β Targets Improves the Cognitive Impairment of APP/PS1/Tau Triple-Transgenic Mouse Models of Alzheimer's Disease.

Journal: Molecular neurobiology

Published: December 06, 2023

An inhibitor with GSK3β and DYRK1A dual inhibitory properties reduces Tau hyperphosphorylation and ameliorates disease in models of Alzheimer's disease.

An inhibitor with GSK3β and DYRK1A dual inhibitory properties reduces Tau hyperphosphorylation and ameliorates disease in models of Alzheimer's disease.

Journal: Neuropharmacology

Published: December 21, 2022

Discovery of novel β-carboline-1,2,3-triazole hybrids as AChE/GSK-3β dual inhibitors for Alzheimer's disease treatment.

Discovery of novel β-carboline-1,2,3-triazole hybrids as AChE/GSK-3β dual inhibitors for Alzheimer's disease treatment.

Journal: Bioorganic chemistry

Published: July 25, 2022

Design, synthesis and biological evaluation of novel coumarin derivatives as multifunctional ligands for the treatment of Alzheimer's disease.

Design, synthesis and biological evaluation of novel coumarin derivatives as multifunctional ligands for the treatment of Alzheimer's disease.

Journal: European journal of medicinal chemistry

Published: May 30, 2022

Yuan-Zhi decoction in the treatment of Alzheimer's disease: An integrated approach based on chemical profiling, network pharmacology, molecular docking and experimental evaluation.

Yuan-Zhi decoction in the treatment of Alzheimer's disease: An integrated approach based on chemical profiling, network pharmacology, molecular docking and experimental evaluation.

Journal: Frontiers in pharmacology

Published: March 10, 2022

Showing 1-12 of 17

Last Updated: 09/26/2026